{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014320","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.882110+00:00","generated_at":"2026-05-19T17:10:10.153752+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Hepion appoints director Kaouthar Lbiati as interim CEO effective June 16","bullets":["Dr. Kaouthar Lbiati, a board member since June 2022, appointed interim CEO effective June 16, 2025.","Initial term of 3 months; annual base salary $350,000 with $50,000 deferred until equity financing ≥$3M or departure.","Performance bonus eligible at 35% of base salary upon milestones; pro-rated bonus if terminated without cause before term end."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014320","json":"https://secwatch.observer/filing/0001641172-25-014320.json","markdown":"https://secwatch.observer/filing/0001641172-25-014320.md","text":"https://secwatch.observer/filing/0001641172-25-014320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225014320/0001641172-25-014320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225014320/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:10:10.153752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4fa0e82af4","claim":"Kaouthar Lbiati was appointed as Interim Chief Executive Officer at Hepion Pharmaceuticals, Inc..","evidence_excerpt":"On June 3, 2025, the Board of Directors of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), approved the appointment of Dr. Kaouthar Lbiati, a director of the Company, as interim Chief Executive Officer, effective June 16, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225014320/0001641172-25-014320-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}